Close mobile menu×
Close mobile menu

Angela M. DiMango, MD

Board Certifications: 
Pulmonary Disease, Internal Medicine
Expertise in: 
Lung Cancer, Cancer Care
Accepting New Patients

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-5730

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor
NY Top Doctor

Board Certifications

  • Pulmonary Disease
  • Internal Medicine

Clinical Expertise

  • Lung Cancer
  • Cancer Care
  • Interstitial Lung Disease
  • Pulmonary Medicine
  • Bronchiectasis
  • Sarcoidosis
  • Emphysema
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma

Education & Training

  • State University of New York - Downstate Health Sciences Center
  • Internship: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

  • 1983 Phi Beta Kappa at New York University
  • 1984 Magna Cum Laude at New York University
  • 1988 Alpha Omega Alpha SUNY Health Sciences Center
  • 1994 Outstanding Teaching Fellow of the Year at Columbia Presbyterian Hospital
  • 1997 Junior Faculty Teaching Award in Pulmonary Medicine Columbia Presbyterian Hospital
  • 2010 Ewig Clinical Scholar Education Award, Columbia University

About Angela DiMango

Academic Titles

  • Associate Professor of Medicine at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
161 Fort Washington Avenue
Suite 323
New York, New York 10032
Phone:
(212) 305-5730
Fax:
(212) 305-0242
Primary

Research

Selected Publications

  • National Emphysema Treatment Trial Research Group (NETT): Advanced Emphysema in African-American and Caucasian Patients. Chest 2006; 130: 108-118.
  • National Emphysema Treatment Trial Research Group (NETT): A randomized trial comparing Lung Volume Reduction Surgery with medical therapy for severe emphysema. New England Journal of Medicine 2003; 348; 2059-73.
  • Rabkin DG, Skaden RN, DiMango A, Steinglass KM, Goldstein DJ: Nitric oxide for the treatment of postpneumonectomy pulmonary edema. Ann Thoracic Surgeryl 2001 Jul:72 (1) 272-274.
  • National Emphysema Treatment Trial Research Group (NETT): Rational and design of the Natiomal Emphysema Treatment Trial (NETT): A prospective randomized tria of lung volume reduction surgery. Journal of Cardiopulmonary Rehabilitation; 20;024-36, 2000.
  • National Emphysema Treatment Trial Research Group: Patients at high risk of death after lung volume reduction surgery. New England Journal of Medicine; 345:1075-83, 2001.
  • AM Dimango, PF Simonelli, M. Argenziano, LA Gorenstein, KM Steinglass, ME Ginsberg, C. Yip, KM Prager, B. Thomashow, J Edsall. (1996) Spirometry and exercise tolerance are significantly imporved in patients who undergo volume reduction pneumectomy for advanced emphysema. American Journal Respiratory Care (153).
  • National Emphysema Treatment Trial Research Group: Rational and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. Chest; 116: 1750-1761, 1999.
  • Washko GR, Fan VS, Ramsey SD, Mohsenifar Z, Martinez F, Make BJ, et al, for the National Emphysema Treatment Trial Research Group: The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med; 177: 164-169, 2008.
  • Lederer DJ, Thomashow BM, Ginsburg ME, Austin JHM, Bartels MN, Yip CK, Jellen PA, Brogan FL, Kawut SM, Maxfield RA, DiMango AM, Simonelli PF, Gorenstein LA, Pearson GDN, Sonett JR. Lung volume reduction surgery for pulmonary emphysema: Improvement in the BODE index after 1 year. J Thorac Cardiovasc Surg 2007;133(6): 1434-8.